Now our material living standards are gradually rising, and the dietary situation of every household has improved greatly. However, it is precisely because everyone eats too well that they suffer from cardiovascular diseases. There are more and more people. Coronary heart disease is a common cardiovascular disease, and there are many patients with this disease. Mailuoning injection is a drug for treating coronary heart disease.
1. What is the efficacy?
The main efficacy of Mailuoning Injection is to clear away heat and nourish yin, activate blood circulation and remove blood clots. Of course, Mailuoning Injection is not only used for these two functions. It can also be used for thromboangiitis obliterans, arteriosclerotic occlusion, cerebral thrombosis and sequelae, venous thrombosis and other diseases. Mailuoning Injection has many functions. of.
2. Instructions
Ingredients:
The main ingredients of this product are Achyranthes bidentata, Scrophulariaceae, Dendrobium, and Honeysuckle.
Dosage form:
Injection
Shape:
This product is a clear liquid from yellow-brown to red-brown.
Functions and Indications:
This product clears away heat and nourishes yin, activates blood circulation and removes blood stasis. It is used for thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, venous thrombosis and other diseases.
Usage and dosage:
Intravenous drip. 10-20ml (1-2 tubes) at a time, add 5% glucose injection or 250-500ml sodium chloride injection and infuse, once a day, 10-14 days as a course of treatment, severe patients can use it continuously for 2- 3 courses of treatment.
Adverse reactions:
This product may occasionally cause skin itching, rash, urticaria, facial flushing, muscle tremors, sweating, dizziness, headache, abdominal pain, diarrhea, nausea and vomiting, etc. Rarely, dyspnea and anaphylactic shock.
Contraindications:
Contraindicated for pregnant women and those with a history of allergies or allergic constitution.
Notes:
1. This product should be used under the guidance of a doctor. 2. When intravenously instilling, the initial speed should be slow, observe for 15-20 minutes, and pay attention to patrol. 3. When adverse reactions are found during clinical use, the drug should be stopped immediately. The symptoms may disappear on their own after stopping the drug or symptomatic treatment may be given as appropriate. 4. This product should not be mixed with other drugs in the same container for infusion. 5. This product cannot be used if it appears turbid, precipitated, or has abnormally deepened color.
Drug Interactions:
There is no information on interactions between this product and other drugs.
Drugs for pregnant and lactating women:
Contraindicated for pregnant women.